Hydrochloric Acid → Efletirizine
Reaction equation
Cl.Cl.[F:3][C:4]1[CH:9]=[CH:8][C:7]([CH:10]([C:24]2[CH:29]=[CH:28][C:27]([F:30])=[CH:26][CH:25]=2)[N:11]2[CH2:16][CH2:15][N:14]([CH2:17][CH2:18][O:19][CH2:20][C:21](N)=[O:22])[CH2:13][CH2:12]2)=[CH:6][CH:5]=1.[Na].[OH-:32].[Na+].Cl>O.C(O)C>[CH:8]1[C:7]([CH:10]([N:11]2[CH2:12][CH2:13][N:14]([CH2:17][CH2:18][O:19][CH2:20][C:21]([OH:32])=[O:22])[CH2:15][CH2:16]2)[C:24]2[CH:25]=[CH:26][C:27]([F:30])=[CH:28][CH:29]=2)=[CH:6][CH:5]=[C:4]([F:3])[CH:9]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
In a round-bottomed flask fitted with a mechanical stirrer, a Nitrogen inlet and a condenser, 30 g (0.065 mole) of 2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxyacetamide dihydrochloride are added to a mixture of 325 ml of ethanol, 130 ml of a 1 N aqueous sodium hydroxyde solution and 62 ml of a 6.3 N aqueous sodium hydroxide solution. The mixture is heated under reflux and under a Nitrogen atmosphere for 1.5 hours. The reaction mixture is then cooled down to room temperature and its pH is adjusted to 5 with 78 ml of a 5 N aqueous hydrochloric acid solution. Water is added, and ethanol is evaporated off under vacuum using a rotary evaporator. The resulting aqueous phase is extracted with dichloromethane. The organic phase is dried over anhydrous sodium sulphate and evaporated to dryness to give 25 g of crude efletirizine as an amorphous solid, 5 g of which are recrystallized in acetonitrile.
Workup
- customIn a round-bottomed flask fitted with a mechanical stirrer, a Nitrogen inlet and a condenser
- temperatureThe mixture is heated
- temperatureunder reflux and under a Nitrogen atmosphere for 1.5 hours
- customethanol is evaporated off under vacuum
- customa rotary evaporator
- extractionThe resulting aqueous phase is extracted with dichloromethane
- dry with materialThe organic phase is dried over anhydrous sodium sulphate
- customevaporated to dryness
Sources & evidence
- ORD record
- ord-0229c57c880f4696a6fc0765df608ffa
- Source dataset
- uspto-grants-2002_01
- Patent number
- US06335331B1
Reaction notes
Loading…